key: cord-0770654-if20n0up authors: Soria-Castro, R.; Meneses-Preza, Y. G.; Rodriguez-Lopez, G. M.; Romero-Ramirez, S.; Sosa-Hernandez, V. A.; Cervantes-Diaz, R.; Perez-Fragoso, A.; Torres-Ruiz, J. J.; Gomez-Martin, D.; Campillo-Navarro, M.; Alvarez-Jimenez, V. D.; Perez-Tapia, S. M.; Chavez-Blanco, A. D.; Estrada-Parra, S.; Maravillas-Montero, J. L.; Chacon-Salinas, R. title: SEVERE COVID-19 IS MARKED BY DYSREGULATED SERUM LEVELS OF CARBOXYPEPTIDASE A3 AND SEROTONIN date: 2021-02-03 journal: nan DOI: 10.1101/2021.02.02.21251020 sha: 8474bef9b0ecd1b4eae707fba910ee535ee9fcea doc_id: 770654 cord_uid: if20n0up The immune response plays a critical role in the pathophysiology of SARS-CoV-2 infection ranging from protection to tissue damage. This is observed in the development of acute respiratory distress syndrome when elevated levels of inflammatory cytokines are detected. Several cells of the immune response are implied in this dysregulated immune response including innate immune cells and T and B cell lymphocytes. Mast cells are abundant resident cells of the respiratory tract, able to rapidly release different inflammatory mediators following stimulation. Recently, mast cells have been associated with tissue damage during viral infections, but little is known about their role in SARS-CoV-2 infection. In this study we examined the profile of mast cell activation markers in the serum of COVID-19 patients. We noticed that SARS-CoV-2 infected patients showed increased carboxypeptidase A3 (CPA3), and decreased serotonin levels in their serum. CPA3 levels correlated with C-reactive protein, the number of circulating neutrophils and quick SOFA. CPA3 in serum was a good biomarker for identifying severe COVID-19 patients, while serotonin was a good predictor of SARS-CoV-2 infection. In summary, our results show that serum CPA3 and serotonin levels are relevant biomarkers during SARS-CoV-2 infection, suggesting that mast cells are relevant players in the inflammatory response in COVID-19, might represent targets for therapeutic intervention. Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. CoV-2 infection. In this study we examined the profile of mast cell activation markers in 53 the serum of COVID-19 patients. We noticed that SARS-CoV-2 infected patients 54 showed increased carboxypeptidase A3 (CPA3), and decreased serotonin levels in their 55 serum. CPA3 levels correlated with C-reactive protein, the number of circulating 56 neutrophils and quick SOFA. CPA3 in serum was a good biomarker for identifying 57 severe COVID-19 patients, while serotonin was a good predictor of SARS-CoV-2 58 infection. In summary, our results show that serum CPA3 and serotonin levels are 59 relevant biomarkers during SARS-CoV-2 infection, suggesting that mast cells are 60 relevant players in the inflammatory response in COVID-19, might represent targets for 61 therapeutic intervention. 62 63 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 3, 2021. identified for the first time in Wuhan, China in late 2019. Since then, the virus has spread 66 across the globe infecting more than 100 million people and causing the death of 2.1 67 million infected individuals (1). 68 SARS-CoV-2 infects cells of the mucosa that express the angiotensin-converting 69 enzyme II or ACE2, which is particularly abundant in type II alveolar cells of the lung and 70 also expressed in other tissues (2). The COVID-19 infection has an incubation period of 71 3-7 days, generating moderate symptoms, such as head and muscle aches, sore throat, 72 nasal congestion, dry cough, fatigue and fever. However, 5-10% of infected patients 73 develop acute respiratory distress syndrome (ARDS), a serious complication that 74 causes respiratory failure leading to high mortality (3). 75 A relevant factor for the development of ARDS in patients with COVID-19 is the 76 exacerbated immune response triggered by the infection, reflected as a cytokine storm 77 in which different cytokines such as IL-1, IL-2, IL-4, IL-6, IL-10, IFN- and TNF- are 78 elevated (4). Besides, COVID-19 patients are known to show profound alterations in cell 79 populations associated with the immune response against viruses, such as monocytes, 80 macrophages, neutrophils, NK cells, B lymphocytes, CD8 + T lymphocytes and memory 81 and regulatory CD4 + lymphocytes (5). However, how mast cells (MC) are affected by 82 SARS-CoV-2 is not well understood. 83 MC are tissue resident leukocytes derived from hematopoietic precursors, distributed 84 throughout the body and abundantly found along the respiratory tract (6). These cells 85 are characterized by presenting many cytoplasmic granules that contain different 86 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint chemical mediators released after activation. Among the molecules abundant in MC 87 granules are tryptase, carboxypeptidase, chymase, serotonin, histamine and TNF-. MC 88 also produce other types of inflammatory mediators including prostaglandins, 89 leukotrienes and reactive nitrogen species. In addition, activated mast cells secrete 90 different de novo synthesized cytokines and chemokines (7). in influenza virus infections, the observed lung tissue damage is due to an excessive 99 inflammatory response characterized by the overproduction of cytokines and 100 chemokines or 'cytokine storm' (10). In murine models of infection with the H5N1 101 influenza virus, treatment of mice with ketotifen, an inhibitor of mast cell activation, 102 reduces damage to lung tissue. Further, the combination of ketotifen with oseltamivir, an 103 antiviral drug, significantly increased mice survival (11). On the other hand, it has been 104 observed that mice deficient in MC show less lung damage when infected with influenza 105 A virus, compared to wild-type mice. Interestingly, this effect was associated with a 106 decreased production of TNF-, CCL2, CCL3, CCL4, CXCL2 and CXCL10, suggesting 107 a crucial role of MC in the 'cytokine storm' triggered by influenza infection (12). 108 Considering that mast cell activation plays a crucial role during the damage induced by 109 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint viral infections and that cytokine storm is a crucial feature during SARS-CoV-2 infection, 110 this study was conducted to evaluate mast cell activation markers in the serum of 111 patients with COVID-19 and determine if they are associated with disease severity. 112 113 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint Patients with COVID-19 and control group were enrolled at Instituto Nacional de 116 Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, between March-April 2020. 117 All participants in this study had COVID-19 suggestive symptoms, but only those 118 showing a positive PCR test for SARS-CoV-2 were considered infected, while PCR 119 negative patients were selected as control. Samples from asthmatic, HIV, cancer, 120 autoimmune or pregnant patients were not included in this study. Serum samples were 121 taken upon admission. Demographic and clinical parameters were collected, and 122 laboratory indicators were tested with conventional methods in COVID-19 patients 123 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint Several MC-derived biomarkers are used to diagnose and predict outcomes in allergic 160 and infectious diseases. Among them, histamine, heparin, carboxypeptidase A3 (CPA3), 161 serotonin, and nitric oxide have been studied (13, 14) . To address whether these 162 Figure 1) . 169 Previous reports indicate that different immune markers are differentially expressed 170 during severe COVID-19 (15). Therefore, we investigated whether mast cell-derived 171 biomarkers were altered depending on COVID-19 severity. We observed that patients 172 with severe disease showed increased levels of CPA3 when compared to those with 173 mild/moderate disease, or individuals in the control group ( Figure 1C ). Serotonin levels 174 were decreased in severe COVID-19 ( Figure 1D ). No other mast cell-associated 175 biomarker evaluated showed significant difference in patients with severe COVID-19, 176 compared to patients with mild/moderate symptoms or controls (Supplementary Figure 177 2). 178 Because CPA3 and serotonin levels were altered in severe COVID-19 patients, we next 179 assessed their correlation with clinical and laboratory parameters. A matrix with 180 Spearman's r coefficient values and representing correlation showed that CPA3 had a 181 stronger correlation with an increased number of clinical and laboratory parameters in 182 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint comparison with serotonin ( Figure 2A) . Furthermore, CPA3 showed significative positive 183 correlation with inflammation associated markers as circulating neutrophils (r=0.291, 184 p=0.0447) ( Figure 2B ) and C-reactive protein (r=0.390, p=0.00703) ( Figure 2D ). 185 Remarkably, CPA3 also associated with disease severity score quick Sepsis-related 186 Organ Failure Assesment (qSOFA), (r=0.335, p=0.00862) ( Figure 2C ). 187 Finally, to evaluate the potential clinical utility of serotonin and CPA3, receiver-operator 188 characteristics (ROC) curves were performed to distinguish SARS-CoV-2 infection. 189 Serotonin showed an acceptable AUC (Area Under the Curve) values that allow to 190 distinguish between infected from non-infected individuals (AUC 0.77) ( Figure 2E ). 191 When ROC curves were analyzed to differentiate between mild/moderate and severe 192 COVID-19 patients, CPA3 (AUC 0.77) was more reliable than serotonin (AUC 0.58) or 193 IL-6 (AUC 0.56) to detect patients with severe disease. This was close to the predictive 194 values seen for C-reactive protein (AUC 0.93) ( Figure 2F ). As a whole, these results 195 suggest a relationship between mast cell activation, as reflected by CPA3 levels in 196 serum, and severe To the best of our knowledge, this is the first evidence of alteration in serum serotonin 198 and CPA3 levels during COVID-19. CPA3 is abundantly expressed in human lungs (16), 199 with MC being the main cell source (Supplementary Figure 3) . CPA3 is an enzyme that 200 cleaves C-terminal amino acid residues from proteins and is an abundant protein in MC 201 granules (16 g CPA3 per 10 6 MC). This enzyme is released after cell degranulation 202 and is associated with allergic pathologies of the respiratory tract (17). Identified 203 substrates for CPA3 include neurotensin, kinetensin, neuromedin N, angiotensin I and 204 endothelin-1, which is associated with pulmonary fibrosis (18), a sequela observed in 205 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. The second marker that was modified during SARS-CoV-2 infection was serotonin. 217 Traditionally serotonin is considered as an important neurotransmitter regulating several 218 neuronal activities in the central nervous system. However, recent evidence indicates 219 that systemic serotonin distributed by the blood plays a more complex function in the 220 organism. Blood serotonin is produced by different cell lineages, including MC, but is 221 mainly produced by enterochromaffin cells of the intestine. Once in the blood, serotonin 222 levels are primarily regulated by platelets which capture and store in dense granules 223 which are secreted after cell activation (23). Previous studies have shown that infections 224 can decrease, increase or maintain serotonin levels in blood (24-26). For instance, in 225 dengue infection decreased levels of serum serotonin were associated with disease 226 severity. Moreover, a correlation is observed between decreased serotonin and 227 thrombocytopenia, a clinical feature of severe dengue, associating decreased serum 228 serotonin with decreased numbers of platelets (24, 26). However, we did not observe a 229 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint difference in platelet count in COVID-19 patients (Supplementary Table 1 In conclusion, our results demonstrate that serum levels of CPA3 and serotonin are 248 affected during SARS-CoV-2 infection and can be considered as biomarkers during 249 COVID-19. We suggest that mast cells play an important role in this disease and that 250 these cells could be considered targets for therapeutic intervention. 251 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The authors declare no conflicts of interest. 269 The data supporting the conclusions of this article will be made available by the authors 270 upon reasonable request. 271 272 273 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint The serum concentration of A, C) Carboxypeptidase A3 (CPA3), and B, D) Serotonin 278 were measured upon patient admission by ELISA. Data from 21 patients with 279 mild/moderate disease, 41 patients with severe COVID-19, and 10 control individuals is 280 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10. 1101 /2021 shown. Data are presented as mean or median ± range, as appropriate. *p<0.05; **p< 281 Wallis test (D) 283 284 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 3, 2021. CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 3, 2021. ; https://doi.org/10.1101/2021.02.02.21251020 doi: medRxiv preprint World Health Organization Coronavirus Disease (COVID-19) Dashboard. 2021 Structural basis for the recognition 303 of SARS-CoV-2 by full-length human ACE2 Epidemiological and 305 clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, 306 China: a descriptive study Profiling serum cytokines in 308 COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors COVID-19: immunopathology and its implications for therapy. Nat Rev 311 Immunol Novel site-specific 313 mast cell subpopulations in the human lung Mast Cells in Lung Homeostasis: Beyond Type I 316 Hypersensitivity Mast Cell Responses to Viruses and 318 Pathogen Products Protective and pathogenic roles for mast cells during 320 viral infections Aberrant 322 innate immune response in lethal infection of macaques with the 1918 influenza virus. 323 Mast cell-induced lung injury in 325 mice infected with H5N1 influenza virus Inflammatory response of mast 327 cells during influenza A virus infection is mediated by active infection and RIG-I 328 signaling Mast Cells and Their Progenitors in Allergic 330 The role of reactive oxygen species and nitric oxide in 332 mast cell-dependent inflammatory processes Mild versus severe COVID-19: Laboratory markers Tissue-based map of the human proteome Novel insights into the 339 biological function of mast cell carboxypeptidase A The emerging role of mast cell proteases in asthma Pulmonary fibrosis and COVID-19: the 343 potential role for antifibrotic therapy Mast cell modulation of neutrophil 345 influx and bacterial clearance at sites of infection through TNF-alpha Lactate dehydrogenase 348 elevations is associated with severity of COVID-19: a meta-analysis Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic 352 Pathway That May Link Interstitial Edema to Immunothrombosis The Effects of Serotonin in Immune Cells. Front 355 Cardiovasc Med Reveals Serotonin as a Predictor of Severe Dengue in the Early Phase of Dengue 358 Fever Metabolite profiling of 360 infection-associated metabolic markers of onchocerciasis Serial Metabolome Changes in a Prospective 363 Cohort of Subjects with Influenza Viral Infection and Comparison with Dengue Fever Platelet gene expression and function in patients with COVID-19 Immune System Activation and 369 Depression: Roles of Serotonin in the Central Nervous System and Periphery Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and 373 activates brain structures involved in nausea and vomiting Serotonin 5-HT2A receptor activation 376 blocks TNF-alpha mediated inflammation in vivo Effects of serotonin and 378 serotonergic agonists and antagonists on the production of tumor necrosis factor alpha 379 and interleukin-6